A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Clinical trial NCT06528314 · RECRUITING

Trial details

NCT number: NCT06528314
Sponsor: Akero Therapeutics, Inc
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

NASH - Nonalcoholic Steatohepatitis MASH - Metabolic Dysfunction-Associated Steatohepatitis

Start date: 2024-09-04
Primary completion: 2030-02-01
Enrollment: 2150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.